Manganese(III) Nitrate Complexes as Bench-Stable Powerful Oxidants.

We report herein a convenient one-pot synthesis for the shelf-stable molecular complex [Mn(NO3)3(OPPh3)2] (2) and describe the properties that make it a powerful and selective one-electron oxidation (deelectronation) reagent. 2 has a high reduction potential of 1.02 V versus ferrocene (MeCN) (1.65 vs normal hydrogen electrode), which is one the highest known among readily available redox agents used in chemical synthesis. 2 exhibits stability toward air in the solid state, can be handled with relative ease, and is soluble in most common laboratory solvents such as MeCN, dichloromethane, and fluorobenzene. 2 is substitutionally labile with respect to the coordinated (pseudo)halide ions enabling the synthesis of other new Mn(III) nitrato complexes also with high reduction potentials ranging from 0.6 to 1.0 V versus ferrocene.

Synthesis of Mn(III)X3 (X = Cl, Br, I) Compounds with Phosphine (R3P) Ligands.

This work details the synthesis and characterization of complexes of the form [MnIIIX3(PR3)2] (X = Cl, Br, I), which is a rare type of coordination compound. Prior to this work, the only mode of synthesis was oxidizing mixtures of MnIIX2 and PR3 with dry air, but these procedures give low yields and variable outcomes. By taking advantage of the starting material [MnIIICl3(OPPh3)2] (1) and other new strategies, we present robust synthetic protocols for both new and known Mn(III) halido phosphine complexes. In addition to [MnIIIX3(PR3)2], these include [MnIIICl2(dmpe)2]+ salts and [LMnIIX3]- manganates (L = phosphine oxide). Furthermore, the full characterization of these [MnIIIX3(PR3)2] species enabled a definitive revisitation of some controversial chemistry surrounding the compounds and products from the dry air oxidation of certain MnIIX2 and phosphine ligand mixtures.

N-Oxide Coordination to Mn(III) Chloride.

We report on the synthesis and characterization of Mn(III) chloride (MnIIICl3) complexes coordinated with N-oxide ylide ligands, namely trimethyl-N-oxide (Me3NO) and pyridine-N-oxide (PyNO). The compounds are reactive and, while isolable in the solid-state at room temperature, readily decompose into Mn(II). For example, "[MnIIICl3(ONMe3)n]" decomposes into the 2D polymeric network compound complex salt [MnII(µ-Cl)3MnII(µ-ONMe3)]n[MnII(µ-Cl)3]n·(Me3NO·HCl)3n (4). The reaction of MnIIICl3 with PyNO forms varied Mn(III) compounds with PyNO coordination and these react with hexamethylbenzene (HMB) to form the chlorinated organic product 1-cloromethyl-2,3,4,5,6-pentamethylbenzene (8). In contrast to N-oxide coordination to Mn(III), the reaction between [MnIIICl3(OPPh3)2] and 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) resulted in electron transfer-forming d5 manganate of the [TEMPO] cation instead of TEMPO-Mn(III) adducts. The reactivity affected by N-oxide coordination is discussed through comparisons with other L-MnIIICl3 complexes within the context of reduction potential.

Experimental and Computational Determination of a M-Cl Homolytic Bond Dissociation Free Energy: Mn(III)Cl-Mediated C-H Cleavage and Chlorination.

This study confirms the hypothesis that [MnCl3(OPPh3)2] (1) and acetonitrile-solvated MnCl3 (i.e., [MnCl3(MeCN)x]) can be used as synthons to prepare Mn(III) chloride complexes with facially coordinating ligands. This was achieved through the preparation and characterization of six new {MnIIICl} complexes using anionic ligands TpH (tris(pyrazolyl)borate) and TpMe (tris(3,5-dimethylpyrazolyl)borate). The MnIII-chloride dissociation and association equilibria (Keq) and MnIII/II reduction potentials were quantified in DCM. These two thermochemical parameters (Keq and E1/2), in addition to the known Cl-atom reduction potential in DCM, enabled the quantification of the Mn-Cl bond dissociation (homolysis) free energy of 21 and 23 ± 7 kcal/mol at room temperature for R = H and Me, respectively. These are in reasonable agreement with the bond dissociation free energy (BDFEM-Cl) of 34 ± 6 kcal/mol calculated using density functional theory. The BDFEM-Cl of 1 was also calculated (25 ± 6 kcal/mol). These energies were used in predictive C-H bond reactivity.

Dinuclear Mn(I) Complexes with Phosphido and Hydrido Bridges: Synthesis, Reactivity, and Hydrogenative Catalysis.

A class of organomanganese hydrogenation catalysts was recently rediscovered. These are simple dinuclear Mn(I) carbonyl compounds with phosphido (PR2 - ) and hydrido (H- ) bridges. This class of compounds has been known since the 1960's, and they have rich coordination chemistry and reactivity. Given their recently discovered potential for catalytic applications, a fresh look at this class of compounds was necessary. Hence, this Review comprehensively covers the synthesis, reactivity, and catalysis of this interesting class of molecules.

Synthesis of a Bench-Stable Manganese(III) Chloride Compound: Coordination Chemistry and Alkene Dichlorination.

The complex [MnCl3(OPPh3)2] (1) is a bench-stable and easily prepared source of MnCl3. It is prepared by treating acetonitrile solvated MnCl3 (2) with Ph3PO and collecting the resulting blue precipitate. 1 is useful in coordination reactions by virtue of the labile Ph3PO ligands, and this is demonstrated through the synthesis of {Tpm*}MnCl3 (3). In addition, methodologies in synthesis that rely on difficult or cumbersome to prepare solutions of reactive MnCl3 can be accomplished using 1 instead. This is demonstrated through alkene dichlorinations in a wide range of solvents, open to air, and with good substrate scope. Light-accelerated halogenation and radical sensitive experiments support a radical mechanism involving stepwise Cl-atom transfer(s) from 1.

Bench-Stable Dinuclear Mn(I) Catalysts in E-Selective Alkyne Semihydrogenation: A Mechanistic Investigation.

Dinuclear manganese hydride complexes of the form [Mn2 (CO)8 (µ-H)(µ-PR2 )] (R=Ph, 1; R=iPr, 2) were used in E-selective alkyne semi-hydrogenation (E-SASH) catalysis. Catalyst speciation studies revealed rich coordination chemistry and the complexes thus formed were isolated and in turn tested as catalysts; the results underscore the importance of dinuclearity in engendering the observed E-selectivity and provide insights into the nature of the active catalyst. The insertion product obtained from treating 2 with (cyclopropylethynyl)benzene contains a cis-alkenyl bridging ligand with the cyclopropyl ring being intact. Treatment of this complex with H2 affords exclusively trans-(2-cyclopropylvinyl)benzene. These results, in addition to other control experiments, indicate a non-radical mechanism for E-SASH, which is highly unusual for Mn-H catalysts. The catalytically active species are virtually inactive towards cis to trans alkene isomerization indicating that the E-selective process is intrinsic and dinuclear complexes play a critical role. A reaction mechanism is proposed accounting for the observed reactivity which is fully consistent with a kinetic analysis of the rate limiting step and is further supported by DFT computations.

Hydrogenative Catalysis with Three-Coordinate Zinc Complexes Supported with PN Ligands is Enhanced Compared to PNP Analogs.

This work details the synthesis, characterization, and catalytic activity of reactive low-coordinate organozinc complexes. The complexes activate hydrogen and they appear to be more active in hydrogenation of ketones and imines than their tridentate pincer analogs. This is thought, in part, to be due to the lack of trailing third phosphorus arm present in previous work. DFT computations reveal a sigma-bond metathesis mechanism is comparable to an alternative aromatization/dearomatization metal-ligand cooperative mechanism.

Development, implementation and evaluation of an evidence-based paediatric early warning system improvement programme: the PUMA mixed methods study.

BACKGROUND: Paediatric mortality rates in the United Kingdom are amongst the highest in Europe. Clinically missed deterioration is a contributory factor. Evidence to support any single intervention to address this problem is limited, but a cumulative body of research highlights the need for a systems approach. METHODS: An evidence-based, theoretically informed, paediatric early warning system improvement programme (PUMA Programme) was developed and implemented in two general hospitals (no onsite Paediatric Intensive Care Unit) and two tertiary hospitals (with onsite Paediatric Intensive Care Unit) in the United Kingdom. Designed to harness local expertise to implement contextually appropriate improvement initiatives, the PUMA Programme includes a propositional model of a paediatric early warning system, system assessment tools, guidance to support improvement initiatives and structured facilitation and support. Each hospital was evaluated using interrupted time series and qualitative case studies. The primary quantitative outcome was a composite metric (adverse events), representing the number of children monthly that experienced one of the following: mortality, cardiac arrest, respiratory arrest, unplanned admission to Paediatric Intensive Care Unit, or unplanned admission to Higher Dependency Unit. System changes were assessed qualitatively through observations of clinical practice and interviews with staff and parents. A qualitative evaluation of implementation processes was undertaken. RESULTS: All sites assessed their paediatric early warning systems and identified areas for improvement. All made contextually appropriate system changes, despite implementation challenges. There was a decline in the adverse event rate trend in three sites; in one site where system wide changes were organisationally supported, the decline was significant (ß = -0.09 (95% CI: - 0.15, - 0.05); p = < 0.001). Changes in trends coincided with implementation of site-specific changes. CONCLUSIONS: System level change to improve paediatric early warning systems can bring about positive impacts on clinical outcomes, but in paediatric practice, where the patient population is smaller and clinical outcomes event rates are low, alternative outcome measures are required to support research and quality improvement beyond large specialist centres, and methodological work on rare events is indicated. With investment in the development of alternative outcome measures and methodologies, programmes like PUMA could improve mortality and morbidity in paediatrics and other patient populations.

CO-Photolysis-Induced H-Atom Transfer from MnIO-H Bonds.

The formation of TEMPOH from a mixture of [Mn(CO)3(µ3-OH)]4 (1) and (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO) is shown to occur through a light-initiated CO photolysis from 1 (illumination at 300-375 nm). One hypothesis is that the loss of carbon monoxide (CO) causes significant O-H bond weakening to render proton-coupled electron transfer (PCET) to TEMPO favorable. For instance, the ground-state O-H bond dissociation free energy (BDFEO-H) of 1 (computed with density functional theory and estimated using effective BDFE reagents) is too high to transfer an H-atom to TEMPO. We also demonstrate that TEMPO and 1 interact in the dark through a hydrogen-bonded "precomplex" (1···TEMPO). We suggest that the PCET reaction that forms TEMPOH is the result of a H-atom-transfer reaction that occurs immediately after photolysis of a CO ligand(s).

Resurgence of Organomanganese(I) Chemistry. Bidentate Manganese(I) Phosphine-Phenol(ate) Complexes.

As part of the United Nations 2019 celebration of the periodic table of elements, we are privileged to present our studies with the element manganese in this Forum Article series. Catalysis with organomanganese(I) complexes has recently emerged as an important area with the discovery that pincer manganese(I) complexes that can activate substrates through metal-ligand cooperative mechanisms are active (de)hydrogenation catalysts. However, this rapidly growing field faces several challenges, and we identify these in this Forum Article. Some of our efforts in addressing these challenges include using alternative precursors to Mn(CO)5Br to prepare manganese(I) dicarbonyl complexes, the latter of which is usually a component of active catalysts. Specifically, the synthesis of a new bidentate phosphine-phenol ligand along with its corresponding coordination chemistry of five new manganese(I) complexes is described. The complexes having two phenol-phenolate moieties interact with the secondary coordination sphere to enable facile loss of the bromido ligand and even one of the CO ligands to afford manganese(I) dicarbonyl centers.

Hole Extraction by Design in Photocatalytic Architectures Interfacing CdSe Quantum Dots with Topochemically Stabilized Tin Vanadium Oxide.

Tackling the complex challenge of harvesting solar energy to generate energy-dense fuels such as hydrogen requires the design of photocatalytic nanoarchitectures interfacing components that synergistically mediate a closely interlinked sequence of light-harvesting, charge separation, charge/mass transport, and catalytic processes. The design of such architectures requires careful consideration of both thermodynamic offsets and interfacial charge-transfer kinetics to ensure long-lived charge carriers that can be delivered at low overpotentials to the appropriate catalytic sites while mitigating parasitic reactions such as photocorrosion. Here we detail the theory-guided design and synthesis of nanowire/quantum dot heterostructures with interfacial electronic structure specifically tailored to promote light-induced charge separation and photocatalytic proton reduction. Topochemical synthesis yields a metastable ß-Sn0.23V2O5 compound exhibiting Sn 5s-derived midgap states ideally positioned to extract photogenerated holes from interfaced CdSe quantum dots. The existence of these midgap states near the upper edge of the valence band (VB) has been confirmed, and ß-Sn0.23V2O5/CdSe heterostructures have been shown to exhibit a 0 eV midgap state-VB offset, which underpins ultrafast subpicosecond hole transfer. The ß-Sn0.23V2O5/CdSe heterostructures are further shown to be viable photocatalytic architectures capable of efficacious hydrogen evolution. The results of this study underscore the criticality of precisely tailoring the electronic structure of semiconductor components to effect rapid charge separation necessary for photocatalysis.

Severity and threshold of peanut reactivity during hospital-based open oral food challenges: An international multicenter survey.

BACKGROUND: Peanut allergy is classically managed by food avoidance. Immunotherapy programs are available at some academic centers for selected patients reacting to small amounts of peanut during food challenge. We aimed to determine and compare reaction thresholds and prevalence of anaphylaxis during peanut oral challenges at multiple specialist allergy centers. METHODS: A retrospective, international survey of anonymized case records from seven specialist pediatric allergy centers from the UK and Ireland, as well as the Australian HealthNuts study. Demographic information, allergy test results, reaction severity and threshold during open oral peanut challenges were collated and analyzed. RESULTS: Of the 1634 children aged 1-18 years old included, 525 (32%) failed their peanut challenge. Twenty-eight percent reacted to 25 mg, while 38% only reacted after consuming 1 g or more of whole peanut. Anaphylaxis (55 [11%]) was 3 times more common in teenagers than younger children and the likelihood increased at all ages as children consuming more peanut at the challenge. Children who developed anaphylaxis to 25-200 mg of whole peanut were significantly older. Previous history of reaction did not predict reaction threshold or severity. CONCLUSIONS: More than a third of the children in this large international cohort tolerated the equivalent of one peanut in an oral challenge. Anaphylaxis, particularly to small amounts of peanut, was more common in older children. Tailored immunotherapy programs might be considered not only for children with low, but also higher reaction thresholds. Whether these programs could prevent heightened sensitivity and anaphylaxis to peanut with age also deserves further study.

A prospective, mixed-methods, before and after study to identify the evidence base for the core components of an effective Paediatric Early Warning System and the development of an implementation package containing those core recommendations for use in the UK: Paediatric early warning system - utilisation and mortality avoidance- the PUMA study protocol.

BACKGROUND: In hospital, staff need to routinely monitor patients to identify those who are seriously ill, so that they receive timely treatment to improve their condition. A Paediatric Early Warning System is a multi-faceted socio-technical system to detect deterioration in children, which may or may not include a track and trigger tool. It functions to monitor, detect and prompt an urgent response to signs of deterioration, with the aim of preventing morbidity and mortality. The purpose of this study is to develop an evidence-based improvement programme to optimise the effectiveness of Paediatric Early Warning Systems in different inpatient contexts, and to evaluate the feasibility and potential effectiveness of the programme in predicting deterioration and triggering timely interventions. METHODS: This study will be conducted in two district and two specialist children's hospitals. It deploys an Interrupted Time Series (ITS) design in conjunction with ethnographic cases studies with embedded process evaluation. Informed by Translational Mobilisation Theory and Normalisation Process Theory, the study is underpinned by a functions based approach to improvement. Workstream (1) will develop an evidence-based improvement programme to optimise Paediatric Early Warning System based on systematic reviews. Workstream (2) consists of observation and recording outcomes in current practice in the four sites, implementation of the improvement programme and concurrent process evaluation, and evaluation of the impact of the programme. Outcomes will be mortality and critical events, unplanned admission to Paediatric Intensive Care (PICU) or Paediatric High Dependency Unit (PHDU), cardiac arrest, respiratory arrest, medical emergencies requiring immediate assistance, reviews by PICU staff, and critical deterioration, with qualitative evidence of the impact of the intervention on Paediatric Early Warning System and learning from the implementation process. DISCUSSION: This paper presents the background, rationale and design for this mixed methods study. This will be the most comprehensive study of Paediatric Early Warning Systems and the first to deploy a functions-based approach to improvement in the UK with the aim to improve paediatric patient safety and reduce mortality. Our findings will inform recommendations about the safety processes for every hospital treating paediatric in-patients across the NHS. TRIAL REGISTRATION: Sponsor: Cardiff University, 30-36 Newport Road, Cardiff, CF24 0DE Sponsor ref.: SPON1362-14. Funder: National Institute for Health Research, Health Services & Delivery Research Programme (NIHR HS&DR) Funder reference: 12/178/17. Research Ethics Committee reference: 15/SW/0084 [13/04/2015]. PROSPERO reference: CRD42015015326 [23/01/2015]. ISRCTN: 94228292 https://doi.org/10.1186/ISRCTN94228292 [date of application 13/05/2015; date of registration: 18/08/2015]. Prospective registration prior to data collection and participant consent commencing in September 2014.

Exploring the Role of Carbonate in the Formation of an Organomanganese Tetramer.

The formation of metal-oxygen clusters is an important chemical transformation in biology and catalysis. For example, the biosynthesis of the oxygen-evolving complex in the enzyme photosystem II is a complicated stepwise process that assembles a catalytically active cluster. Herein we describe the role that carbonato ligands have in the formation of the known tetrameric complex [Mn(CO)3(µ3-OH)]4 (1). Complex 1 is synthesized in one step via the treatment of Mn2(CO)10 with excess Me3NO·2H2O. Alternatively, when anhydrous Me3NO is used, an OH-free synthetic intermediate (2) with carbonato ligands is produced. Complex 2 produces carbon dioxide, Me3NO·2H2O, and 1 when treated with water. Labeling studies reveal that the µ3-OH ligands in 1 are derived from the water and possibly the carbonato ligands in 2.

Photochemical Water-Splitting with Organomanganese Complexes.

Certain organometallic chromophores with water-derived ligands, such as the known [Mn(CO)3(µ3-OH)]4 (1) tetramer, drew our attention as possible platforms to study water-splitting reactions. Herein, we investigate the UV irradiation of various tricarbonyl organomanganese complexes, including 1, and demonstrate that dihydrogen, CO, and hydrogen peroxide form as products in a photochemical water-splitting decomposition reaction. The organic and manganese-containing side products are also characterized. Labeling studies with 18O-1 suggest that the source of oxygen atoms in H2O2 originates from free water that interacts with 1 after photochemical dissociation of CO (1-CO) constituting the oxidative half-reaction of water splitting mediated by 1. Hydrogen production from 1 is the result of several different processes, one of which involves the protons derived from the hydroxido ligands in 1 constituting the reductive half-reaction of water splitting mediated by 1. Other processes that generate H2 are also operative and are described. Collectively the results from the photochemical decomposition of 1 provide an opportunity to propose a mechanism, and it is discussed within the context of developing new strategies for water-splitting reactions with organomanganese complexes.

Reactivity of an FeIV-Oxo Complex with Protons and Oxidants.

High-valent Fe-OH species are often invoked as key intermediates but have only been observed in Compound II of cytochrome P450s. To further address the properties of non-heme FeIV-OH complexes, we demonstrate the reversible protonation of a synthetic FeIV-oxo species containing a tris-urea tripodal ligand. The same protonated FeIV-oxo species can be prepared via oxidation, suggesting that a putative FeV-oxo species was initially generated. Computational, Mössbauer, XAS, and NRVS studies indicate that protonation of the FeIV-oxo complex most likely occurs on the tripodal ligand, which undergoes a structural change that results in the formation of a new intramolecular H-bond with the oxido ligand that aids in stabilizing the protonated adduct. We suggest that similar protonated high-valent Fe-oxo species may occur in the active sites of proteins. This finding further argues for caution when assigning unverified high-valent Fe-OH species to mechanisms.

The cobalt hydride that never was: revisiting Schrauzer's "hydridocobaloxime".

Molecular cobalt-dmg (dmg = dimethylglyoxime) complexes are an important class of electrocatalysts used heavily in mechanistic model studies of the hydrogen evolution reaction (HER). Schrauzer's early isolation of a phosphine-stabilized "[H-Co(III)(dmgH)2P(nBu)3]" complex has long provided circumstantial support for the plausible intermediacy of Co(III)-H species in HER by cobaloximes in solution. Our investigation of this complex has led to a reassignment of its structure as [Co(II)(dmgH)2P(nBu)3], a complex that contains no hydride ligand and dimerizes to form an unsupported Co-Co bond in the solid state. A paramagnetic S = 3/2 impurity that forms during the synthesis of [Co(II)(dmgH)2P(nBu)3] when exposed to adventitious oxygen has also been characterized. This impurity features a (1)H NMR resonance at -5.06 ppm that was recently but erroneously attributed to the hydride resonance of "[H-Co(III)(dmgH)2P(nBu)3]". We draw attention to this reassignment because of its relevance to cobaloxime hydrides and HER catalysis and because Schrauzer's "hydridocobaloxime" is often cited as the primary example of a bona fide hydride that can be isolated and characterized on this widely studied HER platform.

Adrenal responses to a low-dose short synacthen test in children with asthma.

OBJECTIVES: Corticosteroids are known to cause adrenal suppression. The aim of this study was to assess clinical factors affecting responses to a low dose short synacthen test (LDSST) in asthmatic children using corticosteroids. DESIGN: Patients were recruited from secondary care paediatric asthma populations within the UK. PATIENTS: Asthmatic children (5-18 years), receiving corticosteroids, underwent a LDSST (n = 525). MEASUREMENTS: Demographics and corticosteroid doses were tested for association with baseline and peak (stimulated) cortisol concentrations. RESULTS: Baseline cortisol was significantly associated with age (log baseline increased 0·04 nm per year of age, P < 0·0001), but not with gender or corticosteroid dose. Peak cortisol was significantly associated with total corticosteroid cumulative dose (decreased 0·73 nm per 200 mcg/day, P < 0·001) but not with age, gender inhaled/intranasal corticosteroid cumulative dose or number of courses of rescue corticosteroids. Biochemically impaired response (peak cortisol ≤500 nm) occurred in 37·0% (161/435) overall, including children using GINA low (200-500 mcg/day beclomethasone-CFC equivalent 32%, n = 60), medium (501-1000 mcg/day (33%, n = 57) and high (>1000 mcg/day 40%, n = 13) doses of inhaled corticosteroid (ICS) similarly, and 36·6% of those using fluticasone ICS ≥500 mcg/day (71/194). Impaired response was more frequent in patients on regular oral corticosteroids (66%, n = 27, P < 0·001). CONCLUSION: Children with asthma can develop biochemical adrenal suppression at similar frequencies for all ICS preparations and doses. The clinical consequence of biochemical suppression needs further study.

Reduction of CO2 by Pyridine Monoimine Molybdenum Carbonyl Complexes: Cooperative Metal-Ligand Binding of CO2.

[((Ar) PMI)Mo(CO)4 ] complexes (PMI=pyridine monoimine; Ar=Ph, 2,6-di-iso-propylphenyl) were synthesized and their electrochemical properties were probed with cyclic voltammetry and infrared spectroelectrochemistry (IR-SEC). The complexes undergo a reduction at more positive potentials than the related [(bipyridine)Mo(CO)4 ] complex, which is ligand based according to IR-SEC and DFT data. To probe the reaction product in more detail, stoichiometric chemical reduction and subsequent treatment with CO2 resulted in the formation of a new product that is assigned as a ligand-bound carboxylate, [( iPr 2PhPMI)Mo(CO)3 (CO2 )](2-) , by NMR spectroscopic methods. The CO2 adduct [( iPr 2PhPMI)Mo(CO)3 (CO2 )](2-) could not be isolated and fully characterized. However, the C-C coupling between the CO2 molecule and the PDI ligand was confirmed by X-ray crystallographic characterization of one of the decomposition products of [( iPr 2PhPMI)Mo(CO)3 (CO2 )](2-) .